- Clone
- XMG1.2 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
- Isotype
- Rat IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.
Product DetailsProduct Details
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- E. coli-expressed, recombinant mouse IFN-γ
- Formulation
- 0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
- Endotoxin Level
- Less than 1.0 EU/mg of the protein (< 0.1 pg/µg of the protein) as determined by the LAL test.
- Preparation
- The GoInVivo™ antibody was purified by affinity chromatography.
- Concentration
- The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL.
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. This GoInVivo™ solution contains no preservative; handle under aseptic conditions.
- Application
-
ELISA Capture, ELISPOT Capture - Quality tested
CyTOF® - Verified
Neut, ICFC, IHC, WB - Reported in the literature, not verified in house - Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
For in vivo and in vitro applications, we recommend to perform a pilot experiment to determine the optimal concentration to use for each particular experiment. - Application Notes
-
GoInVivo™ products are guaranteed to be pathogen-free based on the IDEXX BioResearch IMPACT test via PCR. For a full listing of pathogens tested, visit the GoInVivo™ Webpage.
ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-? (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-?-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-?. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-? bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-? in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended. - Application References
-
- Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
- Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
- Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
- Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
- Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
- Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
- Ferrick D, et al. 1995. Nature 373:255. (FC)
- Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
- Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
- DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
- Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
- Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
- Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
- Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
- Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
- Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
- Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
- Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
- Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
- Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
- Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
- Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
- Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
- RRID
-
AB_2728447 (BioLegend Cat. No. 505855)
AB_2728447 (BioLegend Cat. No. 505852)
AB_2728447 (BioLegend Cat. No. 505854)
AB_2728447 (BioLegend Cat. No. 505856)
AB_2728447 (BioLegend Cat. No. 505853)
AB_2728447 (BioLegend Cat. No. 505851)
Antigen Details
- Structure
- Cytokine; dimer; 40-80 kD (Mammalian)
- Bioactivity
- Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
- Cell Sources
- CD8+ and CD4+ T cells, NK cells
- Cell Targets
- T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
- Receptors
- IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
- Cell Type
- Tregs
- Biology Area
- Cell Biology, Immunology, Neuroinflammation, Neuroscience
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151. - Regulation
- Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
- Gene ID
- 15978 View all products for this Gene ID
- Specificity (DOES NOT SHOW ON TDS):
- IFN-gamma
- Specificity Alt (DOES NOT SHOW ON TDS):
- IFN-γ
- App Abbreviation (DOES NOT SHOW ON TDS):
- FC
- UniProt
- View information about IFN-gamma on UniProt.org
Related FAQs
Other Formats
View All IFN-γ Reagents Request Custom ConjugationCustomers Also Purchased
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
APC anti-mouse IFN-γ
-
Biotin anti-mouse IFN-γ
-
FITC anti-mouse IFN-γ
-
PE anti-mouse IFN-γ
-
Purified anti-mouse IFN-γ
-
Alexa Fluor® 488 anti-mouse IFN-γ
-
Alexa Fluor® 647 anti-mouse IFN-γ
-
Pacific Blue™ anti-mouse IFN-γ
-
PerCP/Cyanine5.5 anti-mouse IFN-γ
-
PE/Cyanine7 anti-mouse IFN-γ
-
Brilliant Violet 421™ anti-mouse IFN-γ
-
Brilliant Violet 650™ anti-mouse IFN-γ
-
Ultra-LEAF™ Purified anti-mouse IFN-γ
-
Brilliant Violet 711™ anti-mouse IFN-γ
-
Brilliant Violet 785™ anti-mouse IFN-γ
-
Brilliant Violet 605™ anti-mouse IFN-γ
-
Brilliant Violet 510™ anti-mouse IFN-γ
-
Purified anti-mouse IFN-γ (Maxpar® Ready)
-
PE/Dazzle™ 594 anti-mouse IFN-γ
-
Alexa Fluor® 700 anti-mouse IFN-γ
-
APC/Cyanine7 anti-mouse IFN-γ
-
GoInVivo™ Purified anti-mouse IFN-γ
-
APC/Fire™ 750 anti-mouse IFN-γ
-
Spark NIR™ 685 anti-mouse IFN-γ
-
Spark UV™ 387 anti-mouse IFN-γ
-
Brilliant Violet 750™ anti-mouse IFN-γ
Follow Us